Advertisement

Organisation › Details
Bristol-Myers Squibb Co. (BMS) (NYSE: BMY)
Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life. *
![]() |
Start | 1989-10-04 merged |
Group | Bristol-Myers Squibb (BMS) (Group) | |
![]() |
Industry | pharmaceutical |
![]() |
Region | New York, NY |
Country | United States (USA) | |
Street | 430 East 29th Street 14th Floor | |
City | 10016 New York, NY | |
Tel | +1-212-546-4000 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | H: 10,001 to 50,00 (2018-12-31) |
Currency | USD | |
Annual sales | 22,561,000,000 (revenue, total, consolidated (2018) 2018-12-31) | |
Profit | 4,947,000,000 (2018-12-31) | |
Cash | 6,911,000,000 (2018-12-31) | |
* Document for �About Section�: | ||
Record changed: 2021-02-12 |
Advertisement

More documents for Bristol-Myers Squibb (BMS) (Group)
- [1] Evotec SE. (12/17/20). "Press Release: Evotec Achieves Key Milestones in Its Collaboration with Bristol Myers Squibb on Targeted Protein Degradation". Hamburg....
- [2] Evotec SE. (10/8/20). "Press Release: Evotec Achieves Milestone in Neurodegeneration Collaboration with Bristol Myers Squibb". Hamburg....
- [3] BioGeneration Ventures B.V.. (6/24/20). "Press Release: BioGeneration Ventures Closes BGV IV Fund at €105 Million". Naarden....
- [4] ADC Therapeutics S.A.. (4/21/20). "Press Release: ADC Therapeutics Appoints Jennifer Creel as Chief Financial Officer". Lausanne....
- [5] Medicen Paris Region. (4/20/20). "Press Release: Medicen Paris Region Appoints Jessica Leygues as CEO". Paris....
- [6] Cellectis S.A.. (4/13/20). "Press Release: Cellectis Appoints Carrie Brownstein, M.D., as Chief Medical Officer". New York, NY....
- [7] Bristol-Myers Squibb Company. (3/18/20). "Press Release: Bristol Myers Squibb Appoints Elizabeth Mily as Executive Vice President, Strategy & Business Development". New York, NY....
- [8] Oxford Biomedica plc. (3/18/20). "Press Release: Oxford BioMedica Signs License & Clinical Supply Agreement with Juno Therapeutics, Inc., a Bristol-Myers Squibb Company, for LentiVector Platform for CAR-T and TCR-T Therapeutics". Oxford....
- [9] Biocartis Group N.V.. (3/5/20). "Press Release: Biocartis Announces New Immuno-Oncology Project with Bristol-Myers Squibb Aimed at Registration of Idylla MSI test in China". Mechelen....
- [10] Voluntis S.A.. (3/3/20). "Press Release: Voluntis and Bristol-Myers Squibb to Co-develop Digital Therapeutics for Oncology". New York, NY & Paris....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement
![Picture [iito] Back into Ad 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-back-into-ad.jpg)
» top